Zobrazeno 1 - 6
of 6
pro vyhledávání: '"A61P11/00"'
The invention relates to gold (III) compounds as Tartrate Resistant Acid Phosphatase (TRAP) inhibitors, and to uses thereof, like in the treatment of pulmonary diseases like COPD and asthma. The inhibitory compounds have the general formula (A), (B),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::024e3580749682017d6bf5ad8258e494
https://research.rug.nl/en/publications/b6855af1-9aef-4d24-b111-e35529fa5c11
https://research.rug.nl/en/publications/b6855af1-9aef-4d24-b111-e35529fa5c11
The use of Sema7 A polypeptides and polynucleotides in the design of protocols for the treatment of autoimmune disorders, chronic obstructive pulmonary disease, inflammation, psoriasis, wound healing, tissue repair, irritable bowel syndrome, stroke,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::10cbf4739fc2738b06a63b5eaf74a34a
https://register.epo.org/application?number=EP0011873
https://register.epo.org/application?number=EP0011873
The invention relates to gold (III) compounds as Tartrate Resistant Acid Phosphatase (TRAP) inhibitors, and to uses thereof, like in the treatment of pulmonary diseases like COPD and asthma. The inhibitory compounds have the general formula (A), (B),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___01423::618c83c39732c1708a98c14e58a5297c
The invention relates to gold (III) compounds as Tartrate Resistant Acid Phosphatase (TRAP) inhibitors, and to uses thereof, like in the treatment of pulmonary diseases like COPD and asthma. The inhibitory compounds have the general formula (A), (B),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::6450f9118706758c0f6e9e5d047b8535
Autor:
NOVARTIS AG, NOVARTIS ERFIND VERWALT GMBH, HASSAN IAN FRANCIS, CLARKE JEREMY GUY, CUENOUD BERNARD
A medicament containing, separately or together, (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or said salt and (B) a tiotropium salt of a pharmaceutically acceptable acid, for simultaneous, sequential or sep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::eedfd26ac1886689690734940607c9c9
https://register.epo.org/application?number=EP0000958
https://register.epo.org/application?number=EP0000958
Autor:
ALTANA PHARMA AG, STERK GEERT JAN
The compounds of a certain formula 1, in which the given substituents have the meanings as indicated in the description, are novel effective PDE4 inhibitors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::812df6a8b167738bfdf3ecd639d02c5a
https://register.epo.org/application?number=EP0308724
https://register.epo.org/application?number=EP0308724